Radiosensitization of Human Colorectal Cancer Cells by MLN4924

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Technology in Cancer Research and Treatment

• Publication date

  2016-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1177/1533034615588197PMID 26082455
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• P27/Kip1 is responsible for magnolol-induced U373 apoptosis in vitro and in vivo.

  2013cited by this paper
• Cancer statistics, 2013

  2013cited by this paper
• Disrupting Protein NEDDylation with MLN4924 Is a Novel Strategy to Target Cisplatin Resistance in Ovarian Cancer

  2013cited by this paper
• The p21-Dependent Radiosensitization of Human Breast Cancer Cells by MLN4924, an Investigational Inhibitor of NEDD8 Activating Enzyme

  2012cited by this paper
• The Nedd8-activating enzyme inhibitor MLN4924 induces autophagy and apoptosis to suppress liver cancer cell growth.

  2012cited by this paper
• Neoadjuvant treatment response as an early response indicator for patients with rectal cancer.

  2012cited by this paper
• Radiosensitization of human pancreatic cancer cells by MLN4924, an investigational NEDD8-activating enzyme inhibitor.

  2012cited by this paper
• Induction of p21-dependent senescence by an NAE inhibitor, MLN4924, as a mechanism of growth suppression.

  2011cited by this paper
• An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer

  2009cited by this paper
• Targeting NEDD8-Activated Cullin-RING Ligases for the Treatment of Cancer

  2009cited by this paper
• RING domain E3 ubiquitin ligases.

  2009influential reference
• Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer

  2007cited by this paper
• Ubiquitin ligases: cell-cycle control and cancer

  2006cited by this paper
• Determination of Molecular Marker Expression Can Predict Clinical Outcome in Colon Carcinomas

  2004cited by this paper
• Prognostic Value of p27, p53, and Vascular Endothelial Growth Factor in Dukes A and B Colon Cancer Patients Undergoing Potentially Curative Surgery

  2004cited by this paper
• Preoperative versus postoperative chemoradiotherapy for rectal cancer.

  2004cited by this paper
• Loss of p27 expression predicts poor prognosis in patients with Dukes' B stage or proximal colorectal cancer.

  2001cited by this paper
• Multiple functions of p27Kip1 and its alterations in tumor cells: a review

  2000cited by this paper
• The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer.

  1999influential reference
• Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis

  1999cited by this paper
• Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma.

  1998influential reference
• Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients

  1997cited by this paper
• Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer.

  1997influential reference
• Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer

  1997influential reference
• Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas

  1997influential reference
• p27 expression and gastric carcinoma

  1997influential reference
• p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors.

  1995cited by this paper
• Cancer statistics

  1989cited by this paper

• Pevonedistat targeting NEDDylation activating enzyme for human diseases: Underlying mechanisms, clinical studies, and future directions.

  2026cites this paper
• Neddylation inhibition induces DNA double-strand breaks, hampering tumor growth in vivo, and promotes radiosensitivity in PAX3–FOXO1 rhabdomyosarcoma

  2025cites this paper
• MicroRNA-1303 in cancer pathogenesis and therapy: clinical implications for biomarker development and targeted treatment strategies

  2025cites this paper
• The role of neddylation in colorectal cancer and its therapeutic potential

  2025cites this paper
• Modulation of the tumor microenvironment by the ubiquitin–proteasome system in colorectal cancer

  2025cites this paper
• Deciphering the role of neddylation in tumor microenvironment modulation: common outcome of multiple signaling pathways

  2024cites this paper
• The cross talk of ubiquitination and chemotherapy tolerance in colorectal cancer

  2024cites this paper
• Understanding the molecular mechanism responsible for developing therapeutic radiation-induced radioresistance of rectal cancer and improving the clinical outcomes of radiotherapy - A review

  2024cites this paper
• Advancements in colorectal cancer research: Unveiling the cellular and molecular mechanisms of neddylation (Review)

  2024cites this paper
• Post-translational regulation of proto-oncogene ZBTB7A expression by p53 status in cancer cells: HSP90-dependent stabilization vs. p53-KLHL20-ubiquitin proteasomal degradation.

  2023cites this paper
• Targeting cullin neddylation for cancer and fibrotic diseases

  2023cites this paper
• Targeting NEDD8-activating enzyme for cancer therapy: developments, clinical trials, challenges and future research directions

  2023cites this paper
• ALKBH5/YTHDF2‐mediated m6A modification of circAFF2 enhances radiosensitivity of colorectal cancer by inhibiting Cullin neddylation

  2023cites this paper
• Differential Uridyl-diphosphate-Glucuronosyl Transferase 1A enzymatic arsenal explains the specific cytotoxicity of resveratrol towards tumor colorectal cells

  2022cites this paper
• Role of autophagy in tumor response to radiation: Implications for improving radiotherapy

  2022cites this paper
• The Absence of PTEN in Breast Cancer Is a Driver of MLN4924 Resistance

  2021cites this paper
• Targeting Cullin-RING E3 Ligases for Radiosensitization: From NEDDylation Inhibition to PROTACs

  2020cites this paper
• Targeting Protein Neddylation for Cancer Therapy.

  2020cites this paper
• Preclinical studies reveal MLN4924 is a promising new retinoblastoma therapy

  2020cites this paper
• Nedd8-activating enzyme inhibitor MLN4924 (Pevonedistat), inhibits miR-1303 to suppress human breast cancer cell proliferation via targeting p27Kip1.

  2020cites this paper
• Pevonedistat (MLN4924): mechanism of cell death induction and therapeutic potential in colorectal cancer

  2020cites this paper
• Targeting E3 ubiquitin ligases to sensitize cancer radiation therapy

  2019cites this paper
• Epigenetic‐based therapy for colorectal cancer: Prospect and involved mechanisms

  2019cites this paper
• The DNA Replication Machinery as Therapeutic Targets

  2019cites this paper
• Cullin Ring Ubiquitin Ligases (CRLs) in Cancer: Responses to Ionizing Radiation (IR) Treatment

  2019cites this paper
• Protein neddylation and its alterations in human cancers for targeted therapy.

  2018cites this paper
• Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML.

  2018cites this paper
• The Nedd8-activating enzyme inhibitor MLN4924 suppresses colon cancer cell growth via triggering autophagy

  2018cites this paper
• Sensitization of prostate cancer to radiation therapy: Molecules and pathways to target.

  2018cites this paper
• Inhibition of neddylation pathway represses influenza virus replication and pro-inflammatory responses.

  2018cites this paper
• Chromatin-Bound Cullin-Ring Ligases: Regulatory Roles in DNA Replication and Potential Targeting for Cancer Therapy

  2018cites this paper
• The Neddylation Inhibitor Pevonedistat (MLN4924) Suppresses and Radiosensitizes Head and Neck Squamous Carcinoma Cells and Tumors

  2017cites this paper
• Neddylation inhibitor MLN4924 induces G2 cell cycle arrest, DNA damage and sensitizes esophageal squamous cell carcinoma cells to cisplatin.

  2017cites this paper
• Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer

  2017cites this paper
• Radiosensitization by the investigational NEDD8-activating enzyme inhibitor MLN4924 (pevonedistat) in hormone-resistant prostate cancer cells

  2016cites this paper